A latest systematic review and meta-analysis conducted by scientists from institutions across China and the United States has uncovered promising insights into how vitamin D supplementation can significantly impact cardiometabolic health.
Minerva’s shares sink on rejection of schizophrenia drug
The FDA has once again turned away Minerva’s schizophrenia drug roluperidone, requesting “at least one” additional well-controlled study. While roluperidone met the primary endpoint in
February 28, 2024